← back to database

From biopharmaceuticals to medical devices, diagnostics, and healthcare services, OrbiMed is scouting the globe for innovations that will help ensure humanity lives healthier, longer, and more productive lives.

Primary stage
SeedSeries ASeries B
Can also enter at
Growth
Lead / follow
Mostly Follow
Hardware / software
Agnostic
Investment focus
HealthcareBiotech

Investors

David Bonita, Matthew S. Rizzo, Peter Thompson

How to reach them

info@orbimed.com